GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Coretech 5 (XPAR:MLCOT) » Definitions » Other Net Income (Loss)

Coretech 5 (XPAR:MLCOT) Other Net Income (Loss) : €0.00 Mil (TTM As of Dec. 2022)


View and export this data going back to 2016. Start your Free Trial

What is Coretech 5 Other Net Income (Loss)?

Coretech 5's Other Net Income (Loss) for the six months ended in Dec. 2022 was €0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2022 was €0.00 Mil.

Coretech 5 Other Net Income (Loss) Historical Data

The historical data trend for Coretech 5's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coretech 5 Other Net Income (Loss) Chart

Coretech 5 Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only - - - - -

Coretech 5 Semi-Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only - - - - -

Coretech 5 Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2022 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coretech 5 Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Coretech 5's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Coretech 5 (XPAR:MLCOT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Coretech 5 (XPAR:MLCOT) » Definitions » Other Net Income (Loss)
Comparable Companies
XPAR:ALRPD ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085 XPAR:IPN SHSE:600196 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
5 rue de Castiglione, Paris, FRA, 75 001
Website
https://www.coretech5.com
Coretech 5 Formerly Gour Medical AG is a pharmaceutical company. It develops and markets veterinary medicines and specialist pet. Its products include food supplements or nutraceuticals or related medical devices. The products are dedicated to the treatment of pain, allergies, behavioral disorders and improvement of quality of life. It sells its product under the brand Weedley.

Coretech 5 (XPAR:MLCOT) Headlines

No Headlines